UPDATE

Stevanato expands its ready-to-fill glass vial capabilities

By Natalie Morrison

- Last updated on GMT

Related tags: Investment

Stevanato Group has pulled forward the expansion of its EZ-Fill facility in Italy by one year in a bid to dominate a bigger portion of the “rapidly expanding” ready-to-fill vials market.

Thanks to an additional €4m ($5.3m) investment, the Italian glass packaging provider’s new line – at their Padua plant in Italy – can now wash, depyroginate, and sterilize up to 40m containers of their EZ-Fill viles and cartridges per year.

The company said the expansion was to keep up with the demands of the ever expanding ready-to-fill market – now accounting for 2.8bn pieces of the syringes and vials market as a whole, and worth an estimated €1bn.

Sergio Stevanato, president of Stevanato – who provide both containers and the machinery to monitor vials and ampoules – told in-PharmaTechnologist: “We started out by focussing on clinical trials.

“However, with more companies outsourcing none-core activities, saving their capital investments for their traditional lines, there is an increased interest in the market for EZ-fill vials and cartridges.”

He added that with more companies jumping on the outsourcing bandwagon – Stevanato have more than 100 projects in play at the moment – the only way to be effective was to industrialise the process.

General manager Franco Stevanato added: “We decided to pull the project forward because many customers want to expand their company now, not in a year’s time. “

BRIC by BRIC

Previously, EZ-Fill has mainly been supplied to the US and Europe.

However the company says it has now seen a surprising uptick in BRIC (Brazil, Russia, India, China) market interest and is now working on a more global scale.

“We have seen an unpredictable interest worldwide and especially in emerging countries, where new manufacturing pharmaceutical plants are going to be created,”​ added Sergio Stevanato.

“This is a good opportunity for the companies to adopt a configuration fully compatible with our EZ-Fill solution from the onset.”

Mexico

In conjunction with their expansion in Italy, the firm is also doubling capacity at its production facility in Monterrey, Mexico.

Following an initial €4.5m ($6m) investment – expected to hit €30m upon completion – the firm says the 20,000 m2 facility will be capable of supplying glass containers, ampoules, vials and cartridges to the North, South and Central American markets. Thanks to an additional €4m ($5.3m) investment, the Italian glass packaging provider’s new line – at their Padua plant in Italy – can now wash, depyroginate, and sterilize up to 40m containers of their EZ-Fill viles and cartridges per year.

The company said the expansion was to keep up with the demands of the ever expanding ready-to-fill market – now accounting for 2.8bn pieces of the syringes and vials market as a whole, and worth an estimated €1bn.

Sergio Stevanato, president of Stevanato, told in-PharmaTechnologist: “We started out by focussing on clinical trials.

“However, with more companies outsourcing none-core activities, saving their capital investments for their traditional lines, there is an increased interest in the market for EZ-fill vials and cartridges.”

He added that with more companies jumping on the outsourcing bandwagon – Stevanato have more than 100 projects in play at the moment – the only way to be effective was to industrialise the process.

General manager Franco Stevanato added: “We decided to pull the project forward because many customers want to expand their company now, not in a year’s time. “

BRIC by BRIC

Previously, EZ-Fill has mainly been supplied to the US and Europe.

However the company says it has now seen a surprising uptick in BRIC (Brazil, Russia, India, China) market interest and is now working on a more global scale.

“We have seen an unpredictable interest worldwide and especially in emerging countries, where new manufacturing pharmaceutical plants are going to be created,”​ added Sergio Stevanato.

“This is a good opportunity for the companies to adopt a configuration fully compatible with our EZ-Fill solution from the onset.”

Mexico

In conjunction with their expansion in Italy, the firm is also doubling capacity at its production facility in Monterrey, Mexico.

Following an initial €4.5m ($6m) investment – expected to hit €30m upon completion – the firm says the 20,000 m2 facility will be capable of supplying glass containers, ampoules, vials and cartridges to the North, South and Central American markets.

Sergio Stevanato said: “With the second phase expansion we are adding completely new lines, designed and manufactured by our Engineering Division SPAMI, in order to double the global capacity.

“This shift will aim to cover the increasing demand of high quality glass containers for pharmaceutical use coming from North American market but also South and Central American markets.”

Sergio Stevanato said: “With the second phase expansion we are adding completely new lines, designed and manufactured by our Engineering Division SPAMI, in order to double the global capacity.

“This shift will aim to cover the increasing demand of high quality glass containers for pharmaceutical use coming from North American market but also South and Central American markets.”

Related topics: Drug Delivery, Delivery technologies

Related news

Related products

show more

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Related suppliers

Follow us

Products

View more

Webinars